← Back to Screener
ScreenerNewsCompareWatchlist
VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesNewsCompareWatchlist
AnalyzeValuationTotal ReturnDCA CalculatorInsider Activity
HomeStocksSANARevenue History
OverviewPriceRevenueEarningsP/ERatiosDividendTargets

SANA logoSana Biotechnology, Inc. (SANA) Revenue History

Annual and quarterly revenue from 2018 to 2024

TTM Revenue
$0
0
YoY Growth
-
Latest Quarter
$0
Q3 2025
QoQ Growth
-

Compound Annual Growth Rate (CAGR)

3-Year-
5-Year-
10-Year-
Highest Annual Revenue$0 (0)
Highest Quarter$0 ()

Loading revenue history...

SANA Revenue Growth

1-Year Growth
-
3-Year CAGR
-
5-Year CAGR
-
10-Year CAGR
-
TTM vs Prior Year-
Peak Annual Revenue$0 (0)

Download Historical Data

7 records • Includes OHLCV + Technical Indicators (MA50, MA200, RSI)

Free sign in required to download data

SANA Revenue Analysis (2018–2024)

As of May 8, 2026, Sana Biotechnology, Inc. (SANA) generated trailing twelve-month (TTM) revenue of $0. The most recent quarter (Q3 2025) recorded $0 in revenue.

Looking at the longer-term picture, SANA's historical revenue data shows various trends over time.

When compared to Healthcare sector peers including FATE (-51.2% YoY), CRSP (-88.9% YoY), and BEAM (+108.0% YoY). Compare SANA vs FATE →

SANA Revenue vs Peers

Revenue metrics vs comparable public companies

CompanyTTM RevenueYoY Growth5Y CAGROp. MarginCompare
SANA logoSANACurrent$0---
FATE logoFATE$7M-51.2%-26.7%-2222.4%
CRSP logoCRSP$4M-88.9%+37.3%-16191.4%
BEAM logoBEAM$140M+108.0%+466.3%-274.6%
NTLA logoNTLA$68M+16.9%+3.1%-651.7%
Best in groupLowest in group

SANA Historical Revenue Data (2018–2024)

Showing 7 of 7 records
Year Revenue YoY % Gross Profit Gross Margin Op. Income Op. Margin
2024$0-$0-$-272,723,000-
2023$0-$0-$-293,141,000-
2022$0-$0-$-272,564,000-
2021$0-$0-$-356,909,000-
2020$0-$-10,171,000-$-161,123,000-
2019$0-$-3,921,000-$-141,152,000-
2018$0-$-1,000-$-8,221,000-

See SANA's True Return

Price is only half the story. See total return with reinvested dividends.

Launch Calculator

Is SANA Undervalued?

DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.

View Valuation

Compare SANA vs DBVT

Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..

Start Comparison

SANA — Frequently Asked Questions

Quick answers to the most common questions about buying SANA stock.

Is SANA's revenue growth accelerating or slowing?

SANA TTM revenue: $0.00. YoY growth: N/A. 5-year CAGR: N/A.

What is SANA's long-term revenue growth rate?

Sana Biotechnology, Inc.'s 5-year revenue CAGR of N/A reflects the variable expansion pattern. Current YoY growth of N/A is near this long-term average.

How is SANA's revenue distributed by segment?

SANA reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2018-2024 are available for download. Segment mix reveals concentration and diversification trends.

VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Patterns find ideas. Fundamentals build conviction.

Data updated daily

Quick Links

  • Home
  • Screener
  • Themes
  • Market Valuation
  • Valuation
  • Compare
  • Total Return
  • DCA Calculator
  • News
  • Insights
  • Methodology
  • How It Works
  • Profile

Popular Screens

  • VCP Hot
  • VCP Warm
  • Value Screens
  • Growth Screens
  • Momentum Screens
  • Technical Screens
  • Quality Screens

Community

  • Follow @VCPScanner on X

Get weekly stock ideas — free

© 2026 VCP Scanner. All rights reserved.
About·Privacy Policy·Terms of Service
Not financial advice. Do your own research.

SANA Revenue Over Time (2018–2024)